LY2452473 Formulation Exploratory Bioavailability Study

Trial Profile

LY2452473 Formulation Exploratory Bioavailability Study

Phase of Trial: Phase I

Latest Information Update: 12 Sep 2011

At a glance

  • Drugs LY 2452473/tadalafil; Tadalafil; TT 701
  • Indications Erectile dysfunction
  • Focus Pharmacokinetics
  • Most Recent Events

    • 12 Sep 2011 Status changed from active, no longer recruiting to completed as reported by
    • 16 Aug 2011 Status changed from recruiting to active, no longer recruiting as reported by
    • 29 Jul 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top